Recent Advances in Adjuvant Endocrine Therapy in Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer

被引：0
|
作者：
Cobain, Erin F. [1 ]
Hayes, Daniel F. [1 ]
机构：
[1] Univ Michigan, Rogel Canc Ctr, Ann Arbor, MI USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 32期
关键词：
PATIENT-LEVEL METAANALYSIS; RIBOCICLIB PLUS FULVESTRANT; CELL-FREE DNA; POSTMENOPAUSAL WOMEN; MUTATIONS; LETROZOLE; SURVIVAL; TRIAL; MULTICENTER; PALBOCICLIB;
D O I：
10.1200/JCO.22.00702
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：3673 / +
页数：5
相关论文
共 50 条
  • [11] Molecularly targeted therapy and immunotherapy for hormone receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer
    Song, Yuhua
    He, Lin
    Wang, Yaling
    Wu, Qian
    Huang, Wenzhi
    ONCOLOGY REPORTS, 2020, 44 (01) : 3 - 13
  • [12] Impact of palbociclib combinations on treatment of advanced estrogen receptor-positive/human epidermal growth factor 2-negative breast cancer
    Boer, Katalin
    ONCOTARGETS AND THERAPY, 2016, 9 : 6119 - 6125
  • [13] Sacituzumab Govitecan in Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer
    Rugo, Hope S.
    Bardia, Aditya
    Marme, Frederik
    Cortes, Javier
    Schmid, Peter
    Loirat, Delphine
    Tredan, Olivier
    Ciruelos, Eva
    Dalenc, Florence
    Pardo, Patricia Gomez
    Jhaveri, Komal L.
    Delaney, Rosemary
    Fu, Olivia
    Lin, Lanjia
    Verret, Wendy
    Tolaney, Sara M.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (29) : 3365 - +
  • [14] Endocrine Treatment and Targeted Therapy for Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer: ASCO Guideline Update
    Burstein, Harold J.
    Somerfield, Mark R.
    Barton, Debra L.
    Dorris, Ali
    Fallowfield, Lesley J.
    Jain, Dharamvir
    Johnston, Stephen R. D.
    Korde, Larissa A.
    Litton, Jennifer K.
    Macrae, Erin R.
    Peterson, Lindsay L.
    Vikas, Praveen
    Yung, Rachel L.
    Rugo, Hope S.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (35) : 3959 - +
  • [15] Management of hormone receptor-positive, human epidermal growth factor 2-negative metastatic breast cancer
    Mouabbi, Jason A.
    Osborne, C. Kent
    Schiff, Rachel
    Rimawi, Mothaffar F.
    BREAST CANCER RESEARCH AND TREATMENT, 2021, 190 (02) : 189 - 201
  • [16] Combination of Palbociclib and Endocrine Therapy in Hormone Receptor-Positive and Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer With or Without Brain Metastases
    Zhang, Qiuyi
    Lan, Xiaofeng
    Huang, Jiayi
    Xie, Xiaofeng
    Chen, Liping
    Song, Lin
    Bai, Xue
    Chen, Xuelian
    Jing, Haiman
    Du, Caiwen
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2024, 23
  • [17] Tumor biology in estrogen receptor-positive, human epidermal growth factor receptor type 2-negative breast cancer: Mind the menopausal status
    Yamashita, Hiroko
    WORLD JOURNAL OF CLINICAL ONCOLOGY, 2015, 6 (06): : 220 - 224
  • [18] Prognostic value of tumor-infiltrating lymphocytes in estrogen receptor-positive and human epidermal growth factor receptor 2-negative breast cancer
    Honda, Chikako
    Kurozumi, Sasagu
    Katayama, Ayaka
    Hanna-Khalil, Bishoy
    Masuda, Kei
    Nakazawa, Yuko
    Ogino, Misato
    Obayashi, Sayaka
    Yajima, Reina
    Makiguchi, Takaya
    Oyama, Tetsunari
    Horiguchi, Jun
    Shirabe, Ken
    Fujii, Takaaki
    MOLECULAR AND CLINICAL ONCOLOGY, 2021, 15 (06)
  • [19] Safety and Antitumor Activity of Pembrolizumab in Patients with Estrogen Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer
    Rugo, Hope S.
    Delord, Jean-Pierre
    Im, Seock-Ah
    Ott, Patrick A.
    Piha-Paul, Sarina A.
    Bedard, Philippe L.
    Sachdev, Jasgit
    Le Tourneau, Christophe
    van Brummelen, Emilie M. J.
    Varga, Andrea
    Salgado, Roberto
    Loi, Sherene
    Saraf, Sanatan
    Pietrangelo, Dina
    Karantza, Vassiliki
    Tan, Antoinette R.
    CLINICAL CANCER RESEARCH, 2018, 24 (12) : 2804 - 2811
  • [20] Systemic therapy for hormone receptor-positive/human epidermal growth factor receptor 2-negative early stage and metastatic breast cancer
    Huppert, Laura A.
    Gumusay, Ozge
    Idossa, Dame
    Rugo, Hope S.
    CA-A CANCER JOURNAL FOR CLINICIANS, 2023, 73 (05) : 480 - 515
12345